Wockhardt Ltd is India’s 5th largest pharmaceuticals with a global span across 21 countries, including US and the EU. Its 40 years old consistent tradition of caring and innovation resulted in Wockhardt Hospitals Limited (WHL), the most reputed healthcare organisation in India.
Wockhardt Hospitals is the largest chain of Multispecialty Tertiary care hospitals in western India, leader in providing quality healthcare of international standards, with its presence in nine locations: South Mumbai, North Mumbai, Goa, Nagpur, Nasik, Rajkot, Surat & Navi Mumbai. Providing indoor capacity of 2,146 beds, 323 critical beds, it caters to full range of super specialities including rare super specialities like Paediatric, GI, Paediatric Endocrinology, Interventional Neuroradiology, Hematooncology, etc. Wockhardt Hospitals maintains a strict culture of highest quality standards across all the hospitals through its stringently monitored 125 quality indicators, below CDC threshold infection control, vigilant patient safety norms, higher EQuAS ranked labs, shorter turn-around-times processes.
WHL’s 12 years old collaboration with Partners Medical International, Boston, has enabled its access to Harvard’s expertise for knowledge exchange, skill building, and improved clinical acumen. It is the first hospital group in South Asia to be recognised by American Blue Cross and BlueShield Association in its worldwide network of participating hospitals. Also recognised by leading insurance providers across the globe, it is among the fastest growing hospital networks in Asia symbolising state-of-the art and high quality care.Five of its hospitals are NABH accredited, with one of them being near to obtaining JCI international accreditation; path labs achieving NABL accreditations.